PLSE Q2 2025 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0

Gross Profit

-$267,000

Operating Income

-$20M

Net Income

-$19M

EPS (Diluted)

$-0.28

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$120M

Total Liabilities

$16M

Stockholders' Equity

$104M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$267,000	$0	—
Operating Income	-$20M	-$12M	-72.9%
Net Income	-$19M	-$11M	-68.4%